175 related articles for article (PubMed ID: 27784455)
1. [Effects and its mechanism of Nimotuzumab on radiosensitivity of esophageal carcinoma ECA-109 and TE-13 cell lines].
Wang J; Wang W; Guo Y; Jing SW; Shang K; Miao MC; Wang J; Wu YJ; Liu LN; Yu JM
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):732-738. PubMed ID: 27784455
[No Abstract] [Full Text] [Related]
2. Nimotuzumab, an EGFR‑targeted antibody, promotes radiosensitivity of recurrent esophageal squamous cell carcinoma.
Yu Y; Guan H; Jiang L; Li X; Xing L; Sun X
Int J Oncol; 2020 Apr; 56(4):945-956. PubMed ID: 32319582
[TBL] [Abstract][Full Text] [Related]
3. Nimotuzumab enhances the radiosensitivity of cancer cells in vitro by inhibiting radiation-induced DNA damage repair.
Qu YY; Hu SL; Xu XY; Wang RZ; Yu HY; Xu JY; Chen L; Dong GL
PLoS One; 2013; 8(8):e70727. PubMed ID: 23976954
[TBL] [Abstract][Full Text] [Related]
4. [Evodiamine enhances the radiosensitivity of esophageal squamous cell cancer Eca-109 cells].
Feng H; Guo B; Kong X; Wu B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):940-4. PubMed ID: 27363277
[TBL] [Abstract][Full Text] [Related]
5. Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3.
Zhao L; He LR; Xi M; Cai MY; Shen JX; Li QQ; Liao YJ; Qian D; Feng ZZ; Zeng YX; Xie D; Liu MZ
J Transl Med; 2012 Dec; 10():249. PubMed ID: 23232108
[TBL] [Abstract][Full Text] [Related]
6. [Potentials of DNA-PKcs, Ku80, and ATM in enhancing radiosensitivity of cervical carcinoma cells].
Zhuang L; Yu SY; Huang XY; Cao Y; Xiong HH
Ai Zheng; 2007 Jul; 26(7):724-9. PubMed ID: 17626748
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of radiosensitivity in human esophageal carcinoma cells by fenofibrate and its potential mechanism.
Li XQ; Zhou JD; Zou ST; Yu J; Meng XJ; Wu JC
Tumori; 2015; 101(1):123-30. PubMed ID: 25712601
[TBL] [Abstract][Full Text] [Related]
8. The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin.
Zhao L; Li QQ; Zhang R; Xi M; Liao YJ; Qian D; He LR; Zeng YX; Xie D; Liu MZ
Tumour Biol; 2012 Aug; 33(4):1115-23. PubMed ID: 22389159
[TBL] [Abstract][Full Text] [Related]
9. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
[TBL] [Abstract][Full Text] [Related]
10. Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p-EGFR and p-ERK.
Zhao G; Feng L; Ye T; Liu Y; Fan L; Ye C; Chen J
Thorac Cancer; 2023 Aug; 14(22):2127-2138. PubMed ID: 37337933
[TBL] [Abstract][Full Text] [Related]
11. Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.
Wang JL; Yu JP; Sun ZQ; Sun SP
World J Gastroenterol; 2014 Dec; 20(48):18296-305. PubMed ID: 25561796
[TBL] [Abstract][Full Text] [Related]
12. RPA1 expression in esophageal carcinoma and its influence on radiosensitivity of esophageal carcinoma TE-1 cells.
Zhang DJ; Xiang J; Wang X; Wang J; Xiao JC; Xu W; Xu H; Xin Y; Zhang LZ; Pei DS; Zheng JN; Gu YM
Panminerva Med; 2015 Dec; 57(4):183-9. PubMed ID: 26824734
[TBL] [Abstract][Full Text] [Related]
13. [The radiosensitization of nimotuzumab on CAL-27 cells after
Wang X; Gu JM; Meng J; Shao CL
Shanghai Kou Qiang Yi Xue; 2016 Aug; 25(4):409-413. PubMed ID: 27858061
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib sensitizes esophageal squamous cancer cells to radiotherapy by suppressing the expression of HIF-1α and apoptosis proteins.
Wang D; Qin Q; Jiang QJ; Wang DF
J Xray Sci Technol; 2016 Apr; 24(4):639-46. PubMed ID: 27080362
[TBL] [Abstract][Full Text] [Related]
15. Andrographolide radiosensitizes human esophageal cancer cell line ECA109 to radiation in vitro.
Wang ZM; Kang YH; Yang X; Wang JF; Zhang Q; Yang BX; Zhao KL; Xu LP; Yang LP; Ma JX; Huang GH; Cai J; Sun XC
Dis Esophagus; 2016 Jan; 29(1):54-61. PubMed ID: 25059546
[TBL] [Abstract][Full Text] [Related]
16. Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage.
Zhou Z; Lu H; Zhu S; Gomaa A; Chen Z; Yan J; Washington K; El-Rifai W; Dang C; Peng D
J Exp Clin Cancer Res; 2019 Jan; 38(1):13. PubMed ID: 30626422
[TBL] [Abstract][Full Text] [Related]
17. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
18. Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells.
Huang J; Yuan X; Pang Q; Zhang H; Yu J; Yang B; Zhou L; Zhang F; Liu F
Drug Des Devel Ther; 2018; 12():2223-2231. PubMed ID: 30038488
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma.
Yang C; Wang Y; Zhang F; Sun G; Li C; Jing S; Liu Q; Cheng Y
Mol Biol Rep; 2013 Sep; 40(9):5225-35. PubMed ID: 23943380
[TBL] [Abstract][Full Text] [Related]
20. The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism.
Zou K; Liu C; Zhang Z; Zou L
Clinics (Sao Paulo); 2015 Aug; 70(8):556-62. PubMed ID: 26247668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
